73
WFSBP 2015
Wednesday, 17 June 2015
|
Scientific Programme
P-19-019
Differential modulation by working memory performance
on regional brain activation in schizophrenia patients
Leila Shayegan, Germany
Y. Fukuda, T. Katthagen, L. Deserno, J. Kaminski, F. Schla-
genhauf
P-19-020
Gray matter and white matter structural changes in obses-
sive compulsive disorder from the aspect of heterogeneity
Keisuke Ikari, Japan
T. Nakao, K. Okada, S. Hirokuni, K. Murayama, S. Honda,
M. Kuwano, S. Yamada, O. Togao, A. Hiwatashi, S. Kanba
P-19-021
Investigating the predictive value of brain metabolism in
the identification of laterality in temporal lobe epilepsy:
A pattern classification approach
Manuel Schutze, Brazil
D. Rosa, M. Mamede, B. Costa, D. Miranda, M. Brammer,
M. Romano-Silva
P-19-023
Neuroanatomical correlates of schizo-obsessive disorder
Dhanya Raveendranathan, India
J. Narayanaswamy, S. Kalmady, G. Venkatasubramanian,
Y. C. Reddy
P-20
Poster Presentation
12:45–14:15
Muses Foyer
Pharmacology/Stimulation Methods
Chair:
Yannis Zervas, Greece
Co-Chair: Nikos Kokras, Greece
P-20-001
SLC1a1 gene polymorphism and SRI response association
in obsessive compulsive disorder
Tulika Shukla, India
R. Jabeen Taj, M. J. K. Kulkarni, B. Viswanath, M. Purushot-
tam, Y. C. Reddy, S. Jain, P. H. Shetty, T. Kandavel
P-20-002
Relationship between dopaminergic genes polymorphisms
and metabolic syndrome components in schizophrenic
patients treated with antipsychotics
Aurora Arrue, Spain
N. Basterreche, M. I. Zamalloa, A. Arnaiz, O. Olivas, A. Sa-
rasola, U. Picaza, E. Zallo, A. Barreiro, M. Garcia, N. Olaza-
bal, F. J. Garcia, M. Zumárraga
P-20-003
Brain delivery of insulin boosted by intranasal coadminis-
tration with cell-penetrating peptides
Mariko Takeda, Japan
N. Kamei, T. Shingaki, Y. Kanayama, Y. Watanabe
P-20-004
The neuroprotective role of rivastigmine during the treat-
ment with amitriptyline on animal model
Dragos Marinescu, Romania
T. Udristoiu, L. Mogoanta, I. Marinescu
P-20-005
Cognition-enhancing and anxiety-like behavior of the novel
1,4-dihydropiridine derivative in female Alzheimer‘s disease
model-mice
Baiba Jansone, Latvia
I. Kadish, T. van Groen, U. Beitnere, A. Plotniece, K. Pajuste,
V. Klusa
P-20-006
Right side transcranial magnetic stimulation for the treat-
ment of anxious depression
Daniela White, USA
K. Mcdermott
P-20-008
Cognitive function of an adolescent patient with schizo-
phrenia treated with modified electroconvulsive therapy:
A case report
Rie Kuge, Japan
A. Yokota, Y. Morino, J. Ozaki, Y. Kikuchi, T. Ookura